Tamsulosin Hydrochloride Capsules

[21 July 2016]

Products Affected - Description

Tamsulosin Hydrochloride capsule, Mylan
0.4 mg, unit-dose 25 count (NDC 00378-0294-19) - discontinued

Reason for the Shortage

  • Boehringer Ingelheim had tamsulosin capsules on shortage due to production delays.
  • Actavis and Zydus state the reason for the shortage was increased demand.
  • Aurobindo is not marketing the 100 count size.
  • Caraco cannot provide a reason for the shortage.
  • Teva discontinued tamsulosin 0.4 mg capsules in April 2014.
  • Par discontinued tamsulosin 0.4 mg capsules.
  • Sandoz has tamsulosin on shortage due to increased demand for the product.
  • Mylan discontinued tamsulosin 0.4 mg capsules 25 count unit-dose presentations in mid-2016.

Available Products

Flomax capsule, Boehringer Ingelheim
0.4 mg, 100 count (NDC 00597-0166-01)
Tamsulosin Hydrochloride capsule, Actavis
0.4 mg, 100 count (NDC 00228-2996-11)
0.4 mg, 500 count (NDC 00228-2996-50)
Tamsulosin Hydrochloride capsule, Aurobindo
0.4 mg, 500 count (NDC 65862-0598-05)
Tamsulosin Hydrochloride capsule, Caraco
0.4 mg, 90 count (NDC 62756-0160-81)
0.4 mg, 100 count (NDC 62756-0160-88)
0.4 mg, 500 count, NDC 62756-0160-13)
Tamsulosin Hydrochloride capsule, Citron Pharma
0.4 mg, 100 count (NDC 57237-0014-01)
0.4 mg, 500 count (NDC 57237-0014-05)
Tamsulosin Hydrochloride capsule, Mylan
0.4 mg, 90 count (NDC 00378-2500-77)
0.4 mg, unit-dose 100 count (NDC 00378-0294-20)
0.4 mg, 300 count unit-dose (NDC 51079-0294-56)
0.4 mg, 1000 count (NDC 00378-2500-10)
Tamsulosin Hydrochloride capsule, Sandoz
0.4 mg, 100 count (NDC 00781-2076-01)
Tamsulosin Hydrochloride oral capsule, Zydus
0.4 mg, 100 count (NDC 68382-0132-01)
0.4 mg, 1000 count (NDC 68382-0132-10)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages


July 21, April 18, February 2, January 13, 2016; December 16 and 2, November 12, October 29, August 26, July 20 and 7, June 5, May 20 and 8, April 6, March 23 and 3, February 27 and 6, January 27 and 7, 2015; December 23, 19, 17 and 5, October 22, September 18 and 5, August 20 and 15, July 31 and 17, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing